ICD-10-PCS Billable Code

CF141ZZ

Planar Nuclear Medicine Imaging Gallbladder to None with None, Technetium 99m (Tc-99m) Approach

Procedural Specifications

Clinical Axis Detail Definition
SectionC Nuclear Medicine
Body SystemF Hepatobiliary System and Pancreas
Operation1 Planar Nuclear Medicine Imaging
Body Part4 Gallbladder
Approach1 Technetium 99m (Tc-99m)
DeviceZ None
QualifierZ None

Operation Definition

Introduction of radioactive materials into the body for single plane display of images developed from the capture of radioactive emissions

Procedure Overview

Planar nuclear medicine imaging of the hepatobiliary system and pancreas centers on the hepatobiliary iminodiacetic acid (HIDA) scan, in which a radiotracer is injected intravenously, taken up by the liver, and excreted into the bile ducts, gallbladder, and small intestine. A gamma camera captures a series of flat images over roughly one to four hours as the tracer moves through this pathway, showing whether bile flows normally from the liver into the gallbladder and out into the intestine.

The scan is ordered most often to diagnose acute cholecystitis when ultrasound findings are inconclusive, since a gallbladder that fails to fill with tracer strongly suggests obstruction of the cystic duct. It is also used to evaluate biliary leaks after gallbladder surgery or liver transplant, chronic gallbladder dysfunction measured through an ejection fraction after a fatty meal or medication is given, and, less commonly, biliary atresia in infants.

Anatomy & Axis Detail

Gallbladder

The gallbladder is a small, pear-shaped sac tucked against the inferior surface of the liver that stores and concentrates bile between meals, releasing it into the duodenum in response to cholecystokinin. Planar hepatobiliary imaging with a technetium-labeled iminodiacetic acid agent traces this stored bile as it fills the gallbladder, making the study a direct functional test for cystic duct patency and gallbladder contractility rather than a structural picture. Non-visualization after adequate delay is the classic finding in acute cholecystitis, where cystic duct obstruction prevents tracer from entering the sac, while a sluggish or absent response to a fatty meal or sincalide challenge points to chronic dysfunction. Because the gland sits close to the liver's own tracer uptake, timing of sequential planar images is essential to separate gallbladder filling from surrounding hepatic and bowel activity.

Radionuclide: Technetium 99m (Tc-99m)

Technetium 99m (Tc-99m) is the most widely used radionuclide in Nuclear Medicine, valued for its short half-life and favorable gamma energy for imaging bone, cardiac, renal, and other organ systems. In this axis position it records that a technetium-based radiopharmaceutical was the tracer administered for the study, distinguishing it from the many other specific isotopes, such as thallium or iodine compounds, used for more specialized indications.

Coding & Documentation

Coding relies on the report confirming a single-plane, sequential imaging technique rather than a tomographic reconstruction, along with the radioisotope used, typically a technetium-99m labeled iminodiacetic acid derivative. When the study includes a pharmacologic or fatty-meal challenge to calculate a gallbladder ejection fraction, that is part of the same study and does not generate a separate code. A recurring mistake is coding delayed imaging performed hours after the initial injection as a distinct procedure, when it is a continuation of the same planar study and should be captured with a single code.

Commonly Confused With

The main distinction to watch for is Tomographic (Tomo) Nuclear Medicine Imaging of the hepatobiliary system, which would apply only if the camera rotated to build cross-sectional images, something uncommon for standard HIDA protocols but occasionally used for complex biliary anatomy. It is also sometimes confused with liver-spleen scans or sulfur colloid studies that assess liver parenchyma rather than biliary excretion; the tracer type and the structures the report describes as being evaluated, biliary tree versus liver tissue itself, separate the two.